JPRN-UMIN000011172尚未招募4 期
A study on the safety and efficasy of tolvaptan for patients with fluid retention after cardiothoracic surgery - A study on the safety and efficasy of tolvaptan for patients with fluid retention after cardiothoracic surgery
Osaka city university graduate school of medicine0 个研究点目标入组 210 人开始时间: 2013年7月12日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Patients with cardiogenic shock. 2 Patients with cardiac assist device. 3 Patients with disease, complication, and symptom, as follows. 1.Dehydration, 2.Adipsia, 3.Hypertrophic cardiomyopathy, 4.Hepatic coma, 5.Uncontrolled diabetes mellitus, 6.Anuria, 7.Disability of urinary excretion. 4 Amyloid myocarditis. 5 Patients with systolic blood pressure <90mmHg. 6 Patients with serum Na > 147 mEq/L or serum K > 5.5 mEq/L or T - bilirubin > 3.0 mg/dL. 7 Patients otherwise judged by the investigator or subinvestigator to be inappropriate for inclusion in the study.
研究者
相似试验
已完成
不适用
Study of the safety and efficacy of tolvaptan for fluid retention symptoms of right heart failure due to pulmonary hypertensiopulmonary hypertensionJPRN-UMIN000010196Department of Cardiology, Keio University School of Medicine40
招募中
不适用
A study to evaluate effect and safety of Tolvaptan in Nephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor gene.ephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor geneJPRN-UMIN000021708Department of Nephrology and Endocrinology, The University of Tokyo Hospital3
已完成
不适用
ongitudinal Efficacy and Safety Study of Tolvaptan on Autosomal Dominant Polycystic Kidney Disease PatientsAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000021267Autosomal Dominant Polycystic Kidney Disease Research Section, Kyorin University, School of Medicine119
招募中
不适用
Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventionalJPRN-UMIN000008712Division of Kidney and Hypertension, the Jikei University School of Medicine40
已完成
4 期
A study on the safety and effectiveness of tolvaptan for patients with fluid retention after valvular surgeryJPRN-UMIN000009957Osaka University Graduate School of Medicine100